Position in JNJ
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$11,980,526
+$1,593,538 QoQ
Shares Held
47,173
+11.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.31%
of 13F equity value
Holder Rank
#1,002
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TWIN CAPITAL MANAGEMENT INC holds $51,361,248 across 9 Drug Manufacturers - General names. JNJ ranks #2 (23.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,076 | $18,082,608 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
47,173 | $11,980,526 | |
| 3 | AMGN |
Amgen Inc
|
15,782 | $5,714,977 | |
| 4 | MRK |
Merck & Co., Inc.
|
40,649 | $5,223,396 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
80,607 | $4,644,575 | |
| 6 | ABBV |
AbbVie Inc.
|
11,313 | $2,846,803 | |
| 7 | PFE |
Pfizer Inc
|
58,541 | $1,409,667 | |
| 8 | BIIB |
Biogen Inc.
|
4,465 | $964,707 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,980,526 | 47,173 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $10,386,988 | 42,493 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $8,726,253 | 42,166 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $7,934,492 | 42,792 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $8,167,084 | 53,467 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $8,854,529 | 53,392 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $7,991,990 | 55,262 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $8,822,870 | 54,442 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $8,161,866 | 55,842 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $8,734,460 | 55,215 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $9,063,647 | 57,826 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $9,197,660 | 59,054 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $9,672,492 | 58,437 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $10,580,920 | 68,264 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $15,026,908 | 85,066 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $14,116,754 | 86,415 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $15,424,376 | 86,893 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $15,574,086 | 87,875 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $15,901,811 | 92,955 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $16,066,827 | 99,485 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $18,281,856 | 110,974 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $16,615,456 | 101,098 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $18,573,672 | 118,018 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $20,003,070 | 134,357 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $19,318,905 | 137,374 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $18,867,115 | 143,881 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||